A systematic overview of the use of diary cards, quality-of-life questionnaires, and psychometric tests in treatment trials of Helicobacter pylori-positive and -negative non-ulcer dyspepsia

Scandinavian Journal of Gastroenterology

Volumn 34, Issue 3, 1999, Pages 244-249

  Sandha, G S ^a,b   Hunt, R H ^a,b   Veldhuyzen Van Zanten, Sander J O ^a,b,c  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c QUEEN ELIZABETH II HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Diary cards; Helicobacter pylori, meta analysis; Non ulcer dyspepsia; Psychometric tests; Quality of life

Indexed keywords

ANTACID AGENT; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG UTILIZATION; DYSPEPSIA; EPIGASTRIC PAIN; ERADICATION THERAPY; GASTROESOPHAGEAL REFLUX; HEARTBURN; HELICOBACTER PYLORI; HUMAN; MEDICAL INFORMATION; MEDICAL LITERATURE; META ANALYSIS; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; VOMITING;

EID: 0032959612     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529950173636     Document Type: Article

References (76)

1. 1. Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, Petersen TC, Nyren O, Bradley LA, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol 1996;91:660-73.
2. 2. Deruyttere M, Lepoutre L, Heylen H, Samain H, Pennoit H. Cisapride in the management of chronic functional dyspepsia. A multicenter, double-blind, placebo-controlled study. Clin Ther 1987;10:44-51.
3. 3. Francois J, De Nutte N. Non-ulcer dyspepsia: effect of the gastrointestinal prokinetic drug cisapride. Curr Ther Res 1987; 41:891-8.
4. 4. Goethals C, Van de Mierop L. Cisapride in the treatment of chronic functional dyspepsia. Results of a double-blind placebo-controlled crossover study. Curr Ther Res 1987;42:261-7.
5. 5. Hannon R. Efficacy of cisapride in patients with non-ulcer dyspepsia. A placebo-controlled study. Curr Ther Res 1987;42: 814-22.
6. 6. De Nutte N, Van Ganse W, Witterhulghe M, Defrance P. Relief of epigastric pain in non-ulcer dyspepsia: controlled trial of the promotility drug cisapride. Clin Ther 1989;11:62-8.
7. 7. Hausken T, Berstad A. Wide gastric antrum with non-ulcer dyspepsia. Effect of cisapride. Scand J Gastroenterol 1992;27: 427-32.
8. 8. Van Ganse W, Van Damme L, Van de Mierop L, Deruyttere M, Lauwers W, Coenegrachts J. Chronic dyspepsia: double-blind treatment with domperidone (R33812) or a placebo. A multicentre therapeutic evaluation. Curr Ther Res 1978;23:695-701.
9. 9. Bekhti A, Rutgeerts L. Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying. Postgrad Med J 1979;55 Suppl 1:30-2.
10. 10. DeLoose F. Domperidone in chronic dyspepsia: a pilot open study and a multicentre general practice crossover comparison with metoclopramide and placebo. Pharmatherapeutica 1979;2: 140-6.
11. 11. Englert W, Schlich D. A double-blind crossover trial of domperidone in chronic postprandial dyspepsia. Postgrad Med J 1979;51:28-9.
12. 12. Haarmann K, Lebkuchner F, Widmann A, Kief W, Esslinger M. A double-blind study of domperidone in the symptomatic treatment of chronic post-prandial upper gastrointestinal distress. Postgrad Med J 1979;55 Suppl 1:24-7.
13. 13. Van de Mierop L, Rutgeerts L, Van den Langenbergh B, Staessen A. Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 1979;19:244-50.
14. 14. Sarin SK, Sharma P, Chawla YK, Gopinath P, Nundy S. Clinical trial on the effect of domperidone on non-ulcer dyspepsia. Indian J Med Res 1986;83:623-8.
15. 15. Johnson A. Controlled trial of metoclopramide in the treatment of flatulent dyspepsia. Br Med J 1971;2:25-6.
16. 16. MacKinnon M, Willing RL, Whitehead R. Cimetidine in the management of symptomatic patients with duodenitis. A double-blind controlled trial. Dig Dis Sci 1982;27:217-9.
17. 17. Dal Monte P, D'Imperio N, Accardo P, Dariotti S. Pirenzipine in non-ulcer dyspepsia. A double-blind placebo-controlled trial. Scand J Gastroenterol 1983;17 Suppl 72:247-50.
18. 18. Hradsky M, Wikander M. Effect of pirenzipine in the treatment of non-ulcer dyspepsia. A double-blind study. Scand J Gastroenterol 1983;17 Suppl 72:251-2.
19. 19. Gad A, Dobrilla G. Campylobacter pylori and non-ulcer dyspepsia. The final results of a double-blind multicentre trial for treatment with pirenzipine in Italy. Scand J Gastroenterol 1989;24 Suppl 167:39-43.
20. 20. Smith PM, Troughton AH, Gleeson F, Walters J, McCarthy CF. Pirenzipine in non-ulcer dyspepsia: a double-blind multicentre trial. J Int Med Res 1990;18:16-20.
21. 21. Kairaluoma M, Hentilae R, Alavaikko M, Kellosalo J, Stahlberg M, Jalovaara P, et al. Sucralfate versus placebo in the treatment of non-ulcer dyspepsia. Am J Med 1987;83 Suppl 3B:51-5.
22. 22. Skoubo-Kristensen E, Funch-Jensen P, Kruse A, Hanberg-Sorensen F, Amdrup E. Controlled clinical trial with sucralfate in the treatment of macroscopic gastritis. Scand J Gastroenterol 1989;24:716-20.
23. 23. Kleveland PM, Johannessen T, Kristensen P, Loge I, Sandbakken P, Dybdahl J, et al. Effect of pancreatic enzymes in non-ulcer dyspepsia. A pilot study. Scand J Gastroenterol 1990;25: 298-301.
24. 24. Walters JM, Crean P, McCarthy CF. Trimebutine, a new antispasmodic in the treatment of dyspepsia. Irish J Med 1980;73: 380-1.
25. 25. Loffeld RJ, Potters HV, Stobberingh E, Flendrig JA, van Spreeuwel JP, Arends JW. Campylobacter-associated gastritis in patients with non-ulcer dyspepsia: a double-blind placebo-controlled trial with colloidal bismuth subcitrate. Gut 1989;30: 1206-12.
26. 26. Goh KL, Parasakthi N, Peh SC, Wong NW, Lo YL, Puthucheary SD. Helicobacter pylori infection and non-ulcer dyspepsia: the effect of treatment with colloidal bismuth subcitrate. Scand J Gastroenterol 1991;26:1123-31.
27. 27. Glupczyinski Y, Burette A, Labbe M, Deprez C, De Reuck M, Deltenre M. Campylobacter pylori-associated gastritis: a double-blind, placebo-controlled trial with amoxycillin. Am J Gastroenterol 1988;83:365-72.
28. 28. de Groot GH, de Both PS. Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study. Aliment Pharmacol Ther 1997;11:193-9.
29. 29. May B, Kuntz HD, Kieser M, Kohler S. Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzeneimittelforschung 1996;46:1149-53.
30. 30. Corazza GR, Biagi F, Albano O, Porro GB, et al. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial. Ital J Gastroenterol 1996;28:317-23.
31. 31. Tanum L, Malt UF. A new pharmacologic treatment of functional gastrointestinal disorder. A double-blind placebo-controlled trial with mianserin. Scand J Gastroenterol 1996;31: 318-25.
32. 32. al-Quorain A, Larbi EB, al-Shedoki F. A double-blind, randomized, placebo-controlled trial of cisapride in Saudi Arabs with functional dyspepsia. Scand J Gastroenterol 1995;30: 531-4.
33. 33. Kellow JE, Cowan H, Shuter B, Riley JW, Lunzer MR, Eckstein RP, et al. Efficacy of cisapride in functional dyspepsia. Aliment Pharmacol Ther 1995;9:153-60.
34. 34. Arienti V, Corazza GR, Sorge M, Boriani L, Urgenti F, Biagi F, et al. The effects of levosulpiride on gastric and gall-bladder emptying in functional dyspepsia. Aliment Pharmacol Ther 1994;8:631-8.
35. 35. Muller P, Hotz J, Franz E. Ranitidine in the treatment of non-ulcer dyspepsia. A placebo-controlled study in the Federal Republic of Germany. Arzeneimittelforschung 1994;44:1130-2.
36. 36. Tatsuta M, Iishi H. Effect of treatment with liu-jun-zi-tang (TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993;7:459-62.
37. 37. Van Outryve M, De Nutte N, Van Eeghem P, Gooris JP. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind placebo-controlled study. Scand J Gastroenterol 1993;28 Suppl 195: 47-52.
38. 38. LaBrooy S, Lovell D, Misiewicz J. The treatment of non-ulcer dyspepsia. In: Wastell C, Lance P, editors. Cimetidine. The Westminster Hospital Symposium. London: Churchill Livingstone; 1978. p. 131-40.
39. 39. Delattre M, Malesky M, Prinzie A. Symptomatic treatment of non-ulcer dyspepsia with cimetidine. Curr Ther Res 1985;37: 980-91.
40. 40. Kelbaek H, Linde J, Eriksen J, Munkgaard S, Moesgaard F, Bonnevie O. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia. Acta Med Scand 1985;217: 281-7.
41. 41. Kleveland PM, Larsen S, Sandvik L, Kristensen P, Johannessen T, Hafstad PF, et al. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. Scand J Gastroenterol 1985;20:19-24.
42. 42. Nesland A, Berstad A. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes. Scand J Gastroenterol 1985;20:629-35.
43. 43. Lance P, Wastell C, Schiller K. A controlled trial of cimetidine for the treatment of non-ulcer dyspepsia. J Clin Gastroenterol 1986;8:414-8.
44. 44. Nyren O, Adami HO, Bates S, Bergstrom R, Gustavsson S, Loof L, et al. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med 1986;314:339-43.
45. 45. Talley NJ, McNeil D, Hayden A, Piper DW. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzipine in non-ulcer dyspepsia. Gastroenterology 1986; 91:149-56.
46. 46. Gotthard R, Bodemar G, Brodin U, Jonsson KA. Treatment with cimetidine, antacids or placebo inpatients with dyspepsia of unknown origin. Scand J Gastroenterol 1988;27:7-18.
47. 47. Johannessen T, Fjøsne U, Kleveland P, Halvorsen T, Kristensen P, Loge I, et al. Cimetidine responders in non-ulcer dyspepsia. Scand J Gastroenterol 1988;23:327-36.
48. 48. Singal AK, Kumar A, Broor SL. Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized, double-blind, placebo-controlled study. Curr Med Res Opin 1989;11:390-7.
49. 49. Johannessen T, Kristensen P, Petersen H, Fosstvedt D, Loge I, Kleveland PM, et al. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials. Scand J Gastroenterol 1991;26:974-80.
50. 50. Rosch W. Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987;22:161-4.
51. 51. Jian R, Ducrot F, Ruskone A, Chaussade S, Rambaud JC, Modigliani R, et al. Symptomatic, radio nuclide and therapeutic assessment of chronic idiopathic dyspepsia: a double-blind, placebo-controlled evaluation of cisapride. Dig Dis Sci 1989; 34:657-64.
52. 52. Hausken T, Berstad A. Cisapride treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled trial. Scand J Gastroenterol 1992;27:213-7.
53. 53. Champion MC, MacCannell KL, Thomson ABR, Tanton R, Eberhard S, Sullivan SN, et al. A double-blind randomized study of cisapride in the treatment of non-ulcer dyspepsia. Can J Gastroenterol 1997;11:127-34.
54. 54. Yeoh KG, Kang JY, Tay HH, Wee A, Teh M, Choo HP, et al. Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. J Gastroenterol Hepatol 1997;12:13-8.
55. 55. Rokkas T, Pursey C, Uzoechina E, Dorrington L, Simmons NA, Filipe MI, et al. Non-ulcer dyspepsia and short-term De-Nol therapy: a placebo-controlled trial with particular reference to Campylobacter pylori. Gut 1988;29:1386-91.
56. 56. Lambert J, Dunn K, Borromeo M, Korman MG, Hansky J. Campylobacter pylori: a role in non-ulcer dyspepsia. Scand J Gastroenterol 1989;24 Suppl 160:7-13.
57. 57. Kang J, Tay H, Wee A, Guan R, Math MV, Yap I. Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double-blind placebo-controlled study. Gut 1990;31:476-80.
58. 58. Olubuyide I, Ayoola E, Okubanjo A, Atoba MA. Non-ulcer dyspepsia in Nigerians. Clin J Gastroenterol 1986;21 Suppl 124:83-7.
59. 59. Saunders J, Oliver R, Higson D. Dyspepsia: incidence of non-ulcer dyspepsia a controlled trial of in general practice. Br Med J 1986;292:665-8.
60. 60. Farup P, Larsen S, Ulshagen K, Osnes M. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. Scand J Gastroenterol 1991;26:1209-16.
61. 61. Weber R, Berstad A. Low dose antacids and pirenzipine in the treatment of patients with non-ulcer dyspepsia and erosive prepyloric changes. A randomized, double-blind, placebo-controlled trial. Scand J Gastroenterol 1988;23:237-43.
62. 62. Hausken T, Stene-Larsen G, Lange O, Aronsen O, Nerdrum T, Hegbom F, et al. Misoprostol treatment exacerbates abdominal discomfort in patients with non-ulcer dyspepsia and erosive prepyloric changes. A double-blind, placebo-controlled, multicenter study. Scand J Gastroenterol 1990;25:1028-33.
63. 63. Galeone M, Cacioli D, Toti G, Megevand J, Benazzi E, Michetti F. Acidrine in the management of gastritis and duodenitis. A double-blind, placebo-controlled clinical trial. J Int Med Res 1984;12:51-5.
64. 64. Hui WM, Lam SK, Lok ASF, Ng MMT, Wong KL, Fok KH. Sulpiride improves functional dyspepsia: a double-blind controlled study. J Gastroenterol Hepatol 1986;1:391-9.
65. 65. Morgan D, Kraft W, Bender M, Pearson A. Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. Gastroenterology 1988;95:1178-84.
66. 66. Gudjonsson H, Oddsson E, Bjorsson S, Gunnlaugsson O, Theodors A, Jonasson TA, et al. Efficacy of sucralfate in treatment of non-ulcer dyspepsia. A double-blind placebo-controlled study. Scand J Gastroenterol 1993;28:969-72.
67. 67. Fraitag B, Homerin M, Hecketsweiler P. Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of non-ulcer dyspepsia. Dig Dis Sci 1994;4:1072-77.
68. 68. Marshall BJ, Valenzuela JE, McCallum RW, Dooley CP, Guerrant RL, Cohen H, et al. Bismuth subsalicylatession of Helicobacter pylori in non-ulcer dyspepsia: a double-blind placebo controlled. Dig Dis Sci 1993;38:1674-80.
69. 69. Talley NJ, Colin-Jones D, Koch KL, Nyren O, Stanghellini V. Functional dyspepsia: a classification with guidelines for diagnosis and management. Gastroenter Int 1991;4:145-60.
70. 70. Hyland ME, Crocker GR. Validation of an asthma quality of life diary in a clinical trial. Thorax 1995;50:724-30.
71. 71. Russell EBAW, Lee AJ, Garraway WM. Use of a 7-day diary for urinary symptom recording. Eur Urol 1994;26:227-32.
72. 72. Geddes DM, Dones L, Hill E, Law K, Harper PG, Spiro SG, et al. Quality of life during chemotherapy for small cell lung cancer: assessment and use of a daily diary card in a randomized trial. Eur J Cancer 1990;26:484-92.
73. 73. Fayers PM, Bleehan NM, Girling DJ. Assessment of quality of life in small-cell lung cancer using a daily diary card developed by the Medical Research Council Lung Cancer Working Party. Br J Cancer 1991;64:299-306.
74. 74. Harding JP, Hamm LR, Ehsanullah RSB, Heath AT, Sorrells SC, Haw J, et al. Use of a novel electronic data collection system in multicenter studies of irritable bowel syndrome. Aliment Pharmacol Ther 1997;11:1073-6.
75. 75. Hyland ME. Diary assessments of quality of life. Qual Life Newslett 1996;Oct:6-9.
76. 76. MacKenzie CR, Charlson ME. Standards for the use of ordinal scales in clinical trials. Br Med J 1986;292:40-3.